NQQQX | VIGAX | NQQQX / VIGAX | |
Total Expense Ratio | 0.27 | 0.05 | 540% |
Annual Report Gross Expense Ratio | 0.38 | 0.05 | 760% |
Fund Existence | 4 years | 25 years | - |
Gain YTD | 12.879 | 12.745 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 3000 | 333,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.01B | 328B | 1% |
Annual Yield % from dividends | 0.46 | 0.43 | 108% |
Returns for 1 year | 15.86 | 27.22 | 58% |
Returns for 3 years | 67.33 | 96.75 | 70% |
Returns for 5 years | N/A | 100.99 | - |
Returns for 10 years | N/A | 347.47 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PCEMX | 15.95 | 0.21 | +1.33% |
PACE International Em Mkts Eq P | |||
WMGAX | 26.90 | 0.04 | +0.15% |
Macquarie Mid Cap Growth A | |||
MECVX | 15.92 | 0.02 | +0.13% |
NYLI Epoch Capital Growth Investor Class | |||
PUMYX | 15.04 | N/A | N/A |
PACE Small/Medium Co Growth Equity Y | |||
ETIHX | 40.09 | N/A | N/A |
Eventide Healthcare & Life Sciences I |